Aggregation‐Enhanced Sonodynamic Activity of Phthalocyanine–Artesunate Conjugates.

The clinical prospect of sonodynamic therapy (SDT) has not been fully realized due to the scarcity of efficient sonosensitizers. Herein, we designed phthalocyanine–artesunate conjugates (e.g. ZnPcT4A), which could generate up to ca. 10‐fold more reactive oxygen species (ROS) than the known sonosensitizer protoporphyrin IX. Meanwhile, an interesting and significant finding of aggregation‐enhanced sonodynamic activity (AESA) was observed for the first time. ZnPcT4A showed about 60‐fold higher sonodynamic ROS generation in the aggregated form than in the disaggregated form in aqueous solutions. That could be attributed to the boosted ultrasonic cavitation of nanostructures. The level of the AESA effect depended on the aggregation ability of sonosensitizer molecules and the particle size of their aggregates. Moreover, biological studies demonstrated that ZnPcT4A had high anticancer activities and biosafety. This study thus opens up a new avenue the development of efficient organic sonosensitizers. [ABSTRACT FROM AUTHOR]